FIELD: biotechnology.
SUBSTANCE: invention relates to a method of obtaining multicomponent spheroids, including isolation of cells, growth of cell cultures, detachment from the substrate, centrifugation, resuspension, determination of concentration and viability, transfer to a culture medium with an ultra-low adhesive coating, removal of single cells, included in the composition of spheroids, the connection of a suspension of human stromal and immune cells and their introduction into a culture dish with an ultra-low adhesive coating, in which there are spheroids already formed from epithelial tumor and immune cells.
EFFECT: invention is effective for obtaining multicomponent three-dimensional cell constructs.
1 cl, 5 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING TISSUE-ENGINEERED IN VITRO MODEL OF HUMAN HEAD AND NECK SQUAMOUS CELL CARCINOMA | 2023 |
|
RU2825474C1 |
METHOD FOR PRODUCING ORGANOIDS FROM TUMOUR TISSUE OF THE HEAD AND NECK | 2021 |
|
RU2787378C1 |
METHOD FOR INCREASING THE PROLIFERATIVE POTENTIAL OF THREE-DIMENSIONAL TUMOR CELL CULTURES | 2021 |
|
RU2782600C1 |
BIOCOMPOSITE SPHEROID FOR BONE REPAIR AND METHOD OF ITS PREPARATION | 2020 |
|
RU2744732C1 |
METHOD FOR SCREENING ANTITUMOUR PREPARATIONS IN VITRO ON A MULTICOMPONENT CELL TEST SYSTEM | 2018 |
|
RU2695568C1 |
GRAFT-TISSUE-ENGINEERED PERICHONDRIUM FOR CARTILAGE RESTORATION OF SUBJECT | 2023 |
|
RU2822238C1 |
METHOD OF PRODUCING TISSUE-ENGINEERED PERIOSTEUM FROM CELL SPHEROIDS FOR REPAIRING BONE DEFECTS OF SUBJECT | 2022 |
|
RU2819284C2 |
METHOD OF CO-CULTIVATING OF THREE-DIMENSIONAL CELL CULTURES OF HUMAN LOWER RESPIRATORY TRACT TO OBTAIN CELLULAR MODEL FOR IN VITRO STUDIES | 2023 |
|
RU2814138C1 |
METHOD FOR PRODUCING TISSUE-ENGINEERED PERIOSTEUM FROM CELL SPHEROIDS FOR REPAIRING BONE DEFECTS IN PATIENTS | 2023 |
|
RU2818176C1 |
METHOD FOR OBTAINING TISSUE-ENGINEERED PERICHONDRIUM TRANSPLANT BASED ON CELL SPHEROIDS | 2022 |
|
RU2807692C2 |
Authors
Dates
2023-06-23—Published
2022-11-16—Filed